US FDA allows physicians to use convalescent plasma for treating critically ill Covid-19 patients

The FDA notes it is possible that plasma collected from recovered COVID-19 patients, which contains antibodies against SARS-CoV-2, might be effective against the infection. Efficacy and safety must however be determined through clinical trials before routine administration.


Biospace Inc.